Why Scientists Are Turning To Sharks For The Next Generation Of Antibody Therapies
Direct Source Verification:
This story is aggregated from Forbes (forbes.com). Full reporting rights and copyright belong to the primary publisher.
Tiny VNAR molecules from sharks are remarkably stable, can squeeze into molecular hiding places larger antibodies cannot reach and are now being tested for everything from cancer therapies to diagnostics and drug delivery across the blood-brain barrier. The challenge? Turning an ...
Tiny VNAR molecules from sharks are remarkably stable, can squeeze into molecular hiding places larger antibodies cannot reach and are now being tested for everything from cancer therapies to diagnostics and drug delivery across the blood-brain barrier. The challenge? Turning an evolutionary oddity into a safe, long-lasting medicine for humans.
Original Source
https://www.forbes.com/sites/melissacristinamarquez/2026/11/05/why-scientists-are-turning-to-sharks-for-the-next-generation-of-antibody-therapies/
